Fourth Circuit Adopts Objective Reasonableness Standard In Determining Scienter Element Of The False Claims Act – Food, Drugs, Healthcare, Life Sciences
The Fourth Circuit, in United States ex rel. Sheldon v. Allergan Sales, LLC, No. 20-2330, 2022 WL 211172 (4th Cir. Jan. 25, 2022) recently upheld...